Vice President, U.S. Sarcoma Marketing

Role Overview

We give it our all every day because we believe in the power of targeted oncology to change the outlook for people with cancer.

The answers are waiting. Let’s go find them together.

Spring Works Therapeutics, a healthcare company of Merck KGaA, Darmstadt, Germany, is a commercial-stage biopharmaceutical company dedicated to improving the lives of patients with rare tumors.

We developed and are commercializing the first and only FDA and EC approved medicine for adults with desmoid tumors and the first and only FDA and EC approved medicine for both adults and children with neurofibromatosis type 1 associated plexiform neurofibromas (NF1-PN).

At Spring Works, we are committed to finding answers people with rare tumors need. We thrive in an atmosphere of passion and tenacity, fueled by the excitement of the possibilities science may unlock and driven to work with urgency because of the importance of our work. We value authenticity because diverse backgrounds, cultures, styles and abilities can only help us find the answers that people with rare tumors are looking for.

The Vice President, U.S. Sarcoma Marketing is a crucial role within the commercial team. This individual will lead two brand teams and a field marketing team to deliver on our commitment to advance the commercial potential of our rare Sarcoma portfolio and ensure the successful management, execution and measurement of our treatments for Desmoid Tumors (DT) and Tenosynovial Giant Cell Tumors (TGCT).

As a member of the U.S. Rare Tumors Marketing Leadership team, reporting to the Vice President of U.S. Rare Tumors Marketing, this leader will own the commercial vision and execution for our sarcoma portfolio in a fast‑paced setting. They will help to shape brand strategy across two distinct brands and orchestrate regional marketing to drive demand, optimize patient impact, and deliver sustainable growth.

This role requires a strategic leader who thrives in an entrepreneurial environment, balancing brand strategy, launch excellence, and regional activation while building a high‑performing team. The leader will partner closely with the broader Marketing organization, Sales, Medical Affairs, Market Access, Legal, Regulatory, Compliance and external stakeholders to bring innovative therapies to patients with rare sarcomas, establish strong relationships with patient, advocacy, and clinician communities, as well as promote the Company as partner of choice with major stakeholders.

This role spans portfolio vision, brand life‑cycle strategy, launch excellence, evidence‑led positioning, omnichannel execution, and people leadership. Success requires deep oncology / rare disease acumen, strong cross‑functional influence, and a track record of scaling brands in complex, specialist markets.

This role will be required to work onsite 2 days a week (Tuesday and Wednesday) or more depending on business needs. #LI-Hybrid

• Leadership and Team Management
  • Lead and mentor two brand teams and a regional marketing team, fostering a collaborative and high-performance culture.
  • Provide guidance and support in the development and execution of marketing plans for the sarcoma portfolio.
  • Conduct regular performance reviews and provide constructive feedback to team members.
• Strategic Planning and Execution
  • Develop and implement comprehensive marketing strategies to drive awareness, adoption, and market share of sarcoma products.
  • Collaborate with cross-functional teams, including sales, medical affairs, and regulatory, to ensure consistency, alignment and support for marketing initiatives across the sarcoma portfolio.
  • Analyze market trends, competitive landscape, and customer insights to inform strategic decisions.
  • Support the build, execution and measurement of a fully integrated Sarcoma omni-channel strategy grounded in compliant personalization and next‑best‑action.
• Portfolio and Brand Leadership
  • Define and execute a portfolio strategy that maximizes patient impact and commercial value across two sarcoma brands.
  • Lead portfolio positioning, messaging, and lifecycle planning, ensuring differentiation in a competitive rare‑tumor landscape.
  • Drive launch readiness for new indications and line extensions with speed and precision.
  • Develop a deep understanding of disease state, market dynamics, unmet needs, and brand